AUTISM IN REVIEW

Area of Science:

• Neurodevelopmental Disorders
• Genetics
• Neuroimaging

Background:

• Autism spectrum disorders (ASD) are neurodevelopmental conditions characterized by social communication deficits and repetitive behaviors.
• Diagnostic criteria are outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
• Synaptic abnormalities and genetic factors are implicated in ASD pathogenesis.

Purpose of the Study:

• To provide a comprehensive review of autism spectrum disorders.
• To discuss diagnostic criteria, underlying biological mechanisms, and current treatment approaches.

Main Methods:

• Review of existing literature on autism spectrum disorders.
• Analysis of diagnostic criteria from the DSM-5.
• Examination of neuroimaging findings, particularly Diffusion Tensor Magnetic Resonance Imaging (DTMRI).
• Review of pharmacological interventions and their efficacy.

Main Results:

• DTMRI studies reveal white matter tract involvement in individuals with ASD.
• Risperidone and aripiprazole are FDA-approved for irritability in ASD.
• No current medication effectively treats the core social and communication symptoms of ASD.
• Fluoxetine may be used to manage anxiety in autistic patients.

Conclusions:

• Understanding the neurobiological underpinnings of ASD is crucial for developing effective treatments.
• Early and intensive interventions significantly improve prognosis for individuals with ASD.
• While some symptoms can be managed, core deficits in social communication remain a challenge.